NextPlat Corp (NASDAQ:NXPL) Short Interest Down 26.5% in February

NextPlat Corp (NASDAQ:NXPL) saw a significant drop in short interest in February. As of February 28th, there was short interest totalling 84,900 shares, a drop of 26.5% from the February 13th total of 115,500 shares. Based on an average daily volume of 377,200 shares, the short-interest ratio is currently 0.2 days. Currently, 0.6% of the company’s stock are sold short.

Institutional Trading of NextPlat

An institutional investor recently raised its position in NextPlat stock. Geode Capital Management LLC lifted its holdings in shares of NextPlat Corp (NASDAQ:NXPL) by 54.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 165,459 shares of the company’s stock after purchasing an additional 58,402 shares during the period. Geode Capital Management LLC owned about 0.64% of NextPlat worth $179,000 at the end of the most recent reporting period. 1.30% of the stock is owned by institutional investors and hedge funds.

NextPlat Stock Down 5.0 %

Shares of NXPL traded down $0.05 during trading hours on Tuesday, reaching $0.95. 27,611 shares of the stock traded hands, compared to its average volume of 348,044. NextPlat has a 52 week low of $0.71 and a 52 week high of $2.68. The stock has a fifty day simple moving average of $1.05 and a 200 day simple moving average of $1.11. The company has a current ratio of 3.70, a quick ratio of 3.04 and a debt-to-equity ratio of 0.04. The company has a market cap of $24.66 million, a price-to-earnings ratio of -1.40 and a beta of 0.79.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.